Las Vegas, NV -- (SBWIRE) -- 10/24/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Stevia First Corp (OTCMKTS: STVF), Puget Technologies Inc (OTCBB: PUGE), Elite Pharmaceuticals Inc (OTCBB: ELTP), Arrayit Corp (OTCMKTS: ARYC)
Stevia First Corp (OTCMKTS: STVF) managed to keep its gain at 1.36% on above-normal volume of 251,476.00 shares. The stock settled at $0.380 after floating in a range of $0.38 to $0.38. Its latest price has reached market capitalization of $22.46 million. Its 52-week range has been $0.29 to $0.68. Stevia First Corp. , formerly Legend Mining Inc., is a development-stage company. It is an agricultural biotechnology company. The Company is engaged in the cultivation and harvest of stevia leaf and the development of stevia products.
For How Long STVF will fight for Profitability? Read This Trend Analysis report
Puget Technologies Inc (OTCBB: PUGE) traded up on a volume of 148,933.00, higher than its standard daily volume. Shares have gained 9.01% to $1.21. Over the last twelve months and faced a worst price of $0.20. PUGET TECHNOLOGIES, INC. is a development-stage company. The Company is engaged in the distribution of luxury wool bedding sets produced in Germany. The Company’s product includes Lama Wool, Camel Wool, Cashmere Wool and Merino Wool.
For How Long PUGE’s Gloss will Attract Investors? Find out via this report
Elite Pharmaceuticals Inc (OTCBB: ELTP) settled 1.89% higher at $0.129 on below -normal volume of 1.09M shares during the last trading day. The stock has its 12-month high at $0017 and 52-week low price was $0.05. It traded in a range of $0.13 to $0.13 during the last trading day. Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology and the development and manufacture of generic pharmaceuticals.
Why Should Investors Buy ELTP After the Recent Fall? Just Go Here and Find Out
In the last trading session, Arrayit Corp (OTCMKTS: ARYC) was up on high volume, trading at a volume of 282,110.00 versus its average daily volume of 247,186.00 shares. At $0.535, the stock has attained market capitalization of 16.12 million. Arrayit Corporation (Arrayit) is a developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation, biological function and diagnostics. Using Arrayit’s technologies.
Will ARYC Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)